
David Guzo
Examiner (ID: 9040)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1805, 2899 |
| Total Applications | 1205 |
| Issued Applications | 693 |
| Pending Applications | 160 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1420712
[patent_doc_number] => 06503501
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Targetable vector particles'
[patent_app_type] => B1
[patent_app_number] => 09/374909
[patent_app_country] => US
[patent_app_date] => 1999-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7950
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503501.pdf
[firstpage_image] =>[orig_patent_app_number] => 09374909
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/374909 | Targetable vector particles | Aug 12, 1999 | Issued |
| 09/371510 | DNA EXPRESSION SYSTEMS BASED ON ALPHAVIRUSES | Aug 9, 1999 | Abandoned |
Array
(
[id] => 782521
[patent_doc_number] => 06991795
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-31
[patent_title] => 'Protein delivery system using human papillomavirus virus-like particles'
[patent_app_type] => utility
[patent_app_number] => 09/762794
[patent_app_country] => US
[patent_app_date] => 1999-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4334
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/991/06991795.pdf
[firstpage_image] =>[orig_patent_app_number] => 09762794
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/762794 | Protein delivery system using human papillomavirus virus-like particles | Aug 9, 1999 | Issued |
Array
(
[id] => 1531724
[patent_doc_number] => 06410221
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Entomopoxvirus expression system'
[patent_app_type] => B1
[patent_app_number] => 09/370861
[patent_app_country] => US
[patent_app_date] => 1999-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 33
[patent_no_of_words] => 32318
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410221.pdf
[firstpage_image] =>[orig_patent_app_number] => 09370861
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/370861 | Entomopoxvirus expression system | Aug 8, 1999 | Issued |
Array
(
[id] => 1446399
[patent_doc_number] => 06368825
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Baculovirus containing minimal CMV promoter'
[patent_app_type] => B1
[patent_app_number] => 09/364223
[patent_app_country] => US
[patent_app_date] => 1999-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3364
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/368/06368825.pdf
[firstpage_image] =>[orig_patent_app_number] => 09364223
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/364223 | Baculovirus containing minimal CMV promoter | Jul 28, 1999 | Issued |
Array
(
[id] => 4268304
[patent_doc_number] => 06245528
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Latent baculovirus expression system'
[patent_app_type] => 1
[patent_app_number] => 9/361474
[patent_app_country] => US
[patent_app_date] => 1999-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4437
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245528.pdf
[firstpage_image] =>[orig_patent_app_number] => 361474
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/361474 | Latent baculovirus expression system | Jul 26, 1999 | Issued |
Array
(
[id] => 773262
[patent_doc_number] => 07001759
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-21
[patent_title] => 'Compositions and methods for delivery of genetic material'
[patent_app_type] => utility
[patent_app_number] => 09/359975
[patent_app_country] => US
[patent_app_date] => 1999-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 23
[patent_no_of_words] => 30578
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001759.pdf
[firstpage_image] =>[orig_patent_app_number] => 09359975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/359975 | Compositions and methods for delivery of genetic material | Jul 22, 1999 | Issued |
Array
(
[id] => 7643839
[patent_doc_number] => 06429200
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Reverse micelles for delivery of nucleic acids'
[patent_app_type] => B1
[patent_app_number] => 09/354957
[patent_app_country] => US
[patent_app_date] => 1999-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11849
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/429/06429200.pdf
[firstpage_image] =>[orig_patent_app_number] => 09354957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/354957 | Reverse micelles for delivery of nucleic acids | Jul 15, 1999 | Issued |
Array
(
[id] => 4379639
[patent_doc_number] => 06261805
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Sialyiation of N-linked glycoproteins in the baculovirus expression vector system'
[patent_app_type] => 1
[patent_app_number] => 9/353897
[patent_app_country] => US
[patent_app_date] => 1999-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9073
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/261/06261805.pdf
[firstpage_image] =>[orig_patent_app_number] => 353897
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/353897 | Sialyiation of N-linked glycoproteins in the baculovirus expression vector system | Jul 14, 1999 | Issued |
Array
(
[id] => 1502448
[patent_doc_number] => 06465007
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Transgene expression in polarized cells'
[patent_app_type] => B1
[patent_app_number] => 09/340509
[patent_app_country] => US
[patent_app_date] => 1999-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 13398
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465007.pdf
[firstpage_image] =>[orig_patent_app_number] => 09340509
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/340509 | Transgene expression in polarized cells | Jun 30, 1999 | Issued |
Array
(
[id] => 1391555
[patent_doc_number] => 06541219
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Therapeutic Gene'
[patent_app_type] => B1
[patent_app_number] => 09/254832
[patent_app_country] => US
[patent_app_date] => 1999-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 5372
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541219.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254832
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254832 | Therapeutic Gene | Jun 20, 1999 | Issued |
Array
(
[id] => 6278554
[patent_doc_number] => 20020107210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DIABETES'
[patent_app_type] => new
[patent_app_number] => 09/336672
[patent_app_country] => US
[patent_app_date] => 1999-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14405
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107210.pdf
[firstpage_image] =>[orig_patent_app_number] => 09336672
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/336672 | Compositions and methods for the treatment or prevention of autoimmune diabetes | Jun 16, 1999 | Issued |
Array
(
[id] => 1030998
[patent_doc_number] => 06878549
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-12
[patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy'
[patent_app_type] => utility
[patent_app_number] => 09/332803
[patent_app_country] => US
[patent_app_date] => 1999-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 36052
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878549.pdf
[firstpage_image] =>[orig_patent_app_number] => 09332803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/332803 | Packaging systems for human recombinant adenovirus to be used in gene therapy | Jun 13, 1999 | Issued |
Array
(
[id] => 1559296
[patent_doc_number] => 06436638
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Cryptosporidium detection method'
[patent_app_type] => B1
[patent_app_number] => 09/326074
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14199
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09326074
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/326074 | Cryptosporidium detection method | Jun 3, 1999 | Issued |
Array
(
[id] => 1599750
[patent_doc_number] => 06475725
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Recombinant cell clones having increased stability and methods of making and using the same'
[patent_app_type] => B1
[patent_app_number] => 09/324612
[patent_app_country] => US
[patent_app_date] => 1999-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 6736
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09324612
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/324612 | Recombinant cell clones having increased stability and methods of making and using the same | Jun 1, 1999 | Issued |
Array
(
[id] => 788094
[patent_doc_number] => 06987026
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-17
[patent_title] => 'Vector for the transformation of Phaffia rhodozyma and process of transformation thereby'
[patent_app_type] => utility
[patent_app_number] => 09/830691
[patent_app_country] => US
[patent_app_date] => 1999-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5012
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/987/06987026.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830691 | Vector for the transformation of Phaffia rhodozyma and process of transformation thereby | May 28, 1999 | Issued |
Array
(
[id] => 1391847
[patent_doc_number] => 06531123
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => 'Lentiviral vectors'
[patent_app_type] => B1
[patent_app_number] => 09/318138
[patent_app_country] => US
[patent_app_date] => 1999-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 31
[patent_no_of_words] => 60120
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531123.pdf
[firstpage_image] =>[orig_patent_app_number] => 09318138
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/318138 | Lentiviral vectors | May 24, 1999 | Issued |
Array
(
[id] => 1594008
[patent_doc_number] => 06491920
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Polypeptides and DNA encoding same'
[patent_app_type] => B1
[patent_app_number] => 09/317114
[patent_app_country] => US
[patent_app_date] => 1999-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6033
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/491/06491920.pdf
[firstpage_image] =>[orig_patent_app_number] => 09317114
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/317114 | Polypeptides and DNA encoding same | May 23, 1999 | Issued |
Array
(
[id] => 1570098
[patent_doc_number] => 06498027
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Targeted delivery through a cationic amino acid transporter'
[patent_app_type] => B1
[patent_app_number] => 09/315926
[patent_app_country] => US
[patent_app_date] => 1999-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 18216
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498027.pdf
[firstpage_image] =>[orig_patent_app_number] => 09315926
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/315926 | Targeted delivery through a cationic amino acid transporter | May 19, 1999 | Issued |
Array
(
[id] => 4342753
[patent_doc_number] => 06284520
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Process for the production of proteins'
[patent_app_type] => 1
[patent_app_number] => 9/305723
[patent_app_country] => US
[patent_app_date] => 1999-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7117
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284520.pdf
[firstpage_image] =>[orig_patent_app_number] => 305723
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/305723 | Process for the production of proteins | May 4, 1999 | Issued |